Med. praxi. 2010;7(5):241-244

Laboratory diagnosis of herpesviruses

RNDr.Kateřina Roubalová, CSc.
Vidia s. r. o., Jesenice u Prahy

Herpesviruses establish a lifelong persistent infection in their host characterized by periods of latency and reactivation. This biological

property is associated with difficulties in their laboratory diagnosis. For this purpose, indirect diagnostic methods based on the demonstration

of specific antibodies or direct methods for demonstrating viral material in clinical samples are available. In serological tests,

it is necessary to distinguish antibodies that are related to the patient‘s history from those related to active infection. Antibody assay

is mainly useful in diagnosing primary infection. In reactivated infections, in the chronically ill, and in immunodeficient patients, the

interpretation of serological findings is unclear. Direct evidence of infection has a significantly higher informative value in these cases.

The paper provides an overview of available diagnostic methods and describes how they are used, how samples are collected and how

laboratory findings are interpreted.

Keywords: herpesviruses, diagnosis, laboratory methods

Published: June 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Roubalová K. Laboratory diagnosis of herpesviruses. Med. praxi. 2010;7(5):241-244.
Download citation

References

  1. Chiu SS, Cheung CY, Tse CYC, Peiris M. Early diagnosis of primary herpesvirus 6 infection in childhood: serplogy, polymerase chain reaction and virus load. J Infect Dis 1998; 178: 1250-1256. Go to original source... Go to PubMed...
  2. Ward K. The natural history and laboratory diagnosis of human herpesviruses-6 and -7 infections in the immunocompetent. J Clin Virol 2005; 32: 183-193. Go to original source... Go to PubMed...
  3. Holub M, Aster V, Roubalová K, Záhumenský J, Radina J. Doporučený postup pro diagnostiku a terapii genitálního herpesu u žen. Klin. mikrobiol. Inf. lék. 2009; 15/3: 102-107.
  4. Roubalová K, Horáček J, Němeček V, Otavová M, et al. Doporučené metody ve virologické diagnostice. Acta hygien epidemiol mikrobiol 2000; 1: 7-10, 11-12, 23-28, 53-55. Go to original source...
  5. Grangeot-Keros L, Mayaux MJ, Lebon P, Freymuth F, et al. Value of cytomegalovirus (CMV) IgG avidity index for the diagnosis of primary infection in pregnant women. J Infect Dis 1997; 175: 944-946. Go to original source... Go to PubMed...
  6. Grangeot-Keros L, Cointe D. Diagnostc and prognostic markers of HCMV infection. J Clin Virol 2001; 21: 213-221. Go to original source... Go to PubMed...
  7. Ustacelebi S. Diagnosis of herpes simplex virus infections. J Clin Virol 2001; 21: 255-259. Go to original source... Go to PubMed...
  8. Venables P. Epstein Barr virus infection and autoimmunity in rheumatoid arthritis. Ann Rheum Dis 1988; 47: 265-269. Go to original source... Go to PubMed...
  9. McClain NT, Rapp EC, Harley JB, James JA. Infectious mononucleosis patients temporarily recognize a unique cross-reactive epitope of Epstein-Barr virus nuclear antigen 1. J Med Virol 2003; 70: 235-257. Go to original source... Go to PubMed...
  10. Gerna G, Percivalle E, Revello MG, Morini F. Correlation of quantitative human cytomegalovirus pp65-, p72- and p150antigenemia, viremia and circulating endothelial giant cells with clinical symptoms and antiviral treatment in immunocompromissed patients. Clin Diagnost Virol 1993; 1: 47-59. Go to original source... Go to PubMed...
  11. Tang YW, Mitchell PS, Espy MJ, Smith TS, Persing DH. Molecular diagnosis of herpes simplex virus infections in the central nervous system. J Clin Microbiol 1999; 37: 2127-2136. Go to original source... Go to PubMed...
  12. Emery VC, Sabin CA, Cope AV, Gor D. Application of viral load kinetics to identify patients who develop cytomegalovirus disease after transplantation. Lancet 2000; 355: 2032-2036. Go to original source... Go to PubMed...
  13. Berger C, Day P, Meier G, Zingg W, et al. Dynamics of Epstein-Barr virus DNA levels in serum during EBV-associated disease. J Med Virol 2001; 64: 505-512. Go to original source... Go to PubMed...
  14. Kimberlin DW. Neonatal herpes simplex infection. Clin Microbiol Rev 2004; 17: 1-13. Go to original source... Go to PubMed...
  15. Revello MG, Gerna G. Pathogenesis and prenatal diagnosis of cytomegalovirus infection. J Clin Virol 2004; 29: 71-83. Go to original source... Go to PubMed...
  16. Maurmann S, Fricke L, Wagner HJ, et al. Molecular parameters for precise diagnosis of asymptomatic Epstein-barr virus reactivation in healthy carriers. J Clin Microbiol 2003; 41: 5419-5428. Go to original source... Go to PubMed...
  17. Maeda A, Wakiguchi H, Yokohama W, Hisakawa H, et al. persistently high Epstein-Barr Virus (EBV) loads in peripheral blood lymphocytes from patients with chronic active EBV infection. J Infect Dis 1999; 179: 1012-1015. Go to original source... Go to PubMed...
  18. Hamilton-Dutoit SJ, Raphael M, Audouin J, Diebold J, et al. In situ demonstration of Epstein Barr virus small RNAs (EBER1) in aquired immunodeficiency syndrome-related lymphomas: correlation with tumor morphology and primary site. Blood 1993; 82: 619-624. Go to original source...




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.